Marwa M Afifi

10PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Craniofacial biologyCell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 24, 2026
Periductal Fibroblast Density Defines Lymphocyte Exclusion via a CD44-Dependent Stromal Checkpoint in Pancreatic Cancer.

|Oct 28, 2025
Fibroblast activation protein promotes natural killer cell invasion and tumor infiltration.

Rachael E Maynard, Allison A Fitzgerald, Emily F Marcisak

|Feb 11, 2025
Targeting c-MYC and gain-of-function p53 through inhibition or degradation of the kinase LZK suppresses the growth of HNSCC tumors.

Amy L Funk, Meghri Katerji, Marwa Afifi

|Jun 10, 2024
Author Correction: Loss of CDK4/6 activity in S/G2 phase leads to cell cycle reversal.

James A Cornwell, Adrijana Crncec, Marwa M Afifi

|Jul 05, 2023
Loss of CDK4/6 activity in S/G2 phase leads to cell cycle reversal.

James A Cornwell, Adrijana Crncec, Marwa M Afifi

|Oct 26, 2022
Revealing β-TrCP activity dynamics in live cells with a genetically encoded biosensor.

Debasish Paul, Stephen C Kales, James A Cornwell

Pageof 2

Frequent Collaborators

5 joint publications

Steven D Cappell

3 joint publications

James A Cornwell

2 joint publications

Iman M Talaat

2 joint publications

Kristina Tang